 |
Journal articles
A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus
Abstract : Zika virus, a member of the Flaviviridae family, is primarily transmitted by infected Aedes species mosquitoes. In 2016, Zika infection emerged as a global health emergency for its explosive spread and the remarkable neurological defects in the developing fetus. Development of a safe and effective Zika vaccine remains a high priority owing to the risk of re-emergence and limited understanding of Zika virus epidemiology. We engineered a non-integrating lentiviralvector(NILV)-based Zika vaccine encoding the consensus pre-membrane and envelope glycoprotein of circulating Zika virus strains. We further evaluated the immunogenicity and protective efficacy of this vaccine in both immunocompromised and immunocompetent mouse models. A single immunization in both mouse models elicited a robust neutralizing antibody titer and afforded full protection against Zika challenge as early as 7 days post-immunization. This NILV-based vaccine also induced a long-lasting immunity when immunized mice were challenged 6 months after immunization. Altogether, our NILV Zika vaccine provides a rapid yet durable protection through a single dose of immunization without extra adjuvant formulation. Our data suggest a promising Zika vaccine candidate for an emergency situation, and demonstrate the capacity of lentiviral vector as an efficient vaccine delivery platform.
Keywords :
non-integrating lentiviral vector
Zika vaccine
Cited literature [60 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-02864026
Contributor : Stephane Petres <>
Submitted on : Wednesday, June 10, 2020 - 6:27:04 PM
Last modification on : Sunday, July 4, 2021 - 3:08:06 AM
Contributor : Stephane Petres <>
Submitted on : Wednesday, June 10, 2020 - 6:27:04 PM
Last modification on : Sunday, July 4, 2021 - 3:08:06 AM
File
A Single Dose of NILV-Based Va...
Publication funded by an institution
Licence
Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License